References:
1) Sajid MS, Ahmed N, Desai M, Baker D, Hamilton G. Upper limb deep vein thrombosis: a literature review to streamline the protocol for management. Acta haematologica. 2007;118(1):10-18.
2) Joffe HV, Goldhaber SZ. Upper-extremity deep vein thrombosis. Circulation. 2002;106(14):1874-1880.
3) Chen AW, Yazdani KO, Candilio L. Upper Limb Deep Vein Thrombosis: A Case Report of an Increasingly Common Condition. The Journal of Tehran University Heart Center. 2018;13(2):73.
4) Ashraf O, Young M, Malik KJ, Cheema T. Systemic complications of COVID-19. Critical care nursing quarterly. 2020;43(4):390-399.
5) Karimi M, Zarei T, Haghpanah S, et al. Efficacy and safety of sinopharm vaccine for SARS-CoV-2 and breakthrough infections in iranian patients with hemoglobinopathies: a preliminary report. Mediterranean Journal of Hematology and Infectious Diseases. 2022;14(1)
6) Ghiasi N, Valizadeh R, Arabsorkhi M, et al. Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion. Immunopathologia Persa. 2021;7(2):e31-e31.
7) AlHosani FI, Stanciole AE, Aden B, et al. Impact of the Sinopharm’s BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE). Vaccine. 2022;40(13):2003-2010.
8) Liu T, Dai J, Yang Z, et al. Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort. Science bulletin. 2021;66(22):2312-2319.
9) Tan BK, Mainbourg S, Friggeri A, et al. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax. 2021;76(10):970-979.
10) Konstantinides SV. Thrombotic complications of vaccination against SARS-CoV-2: what pharmacovigilance reports tell us–and what they don’t. Eur Respiratory Soc; 2021.
11) Kim AY, Woo W, Yon DK, et al. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a systematic review and meta-analysis. International Journal of Infectious Diseases. 2022;
12) Hameed S, Khan AF, Khan S, Wasay M. First report of cerebral venous thrombosis following inactivated-virus covid vaccination (Sinopharm and Sinovac). Journal of Stroke and Cerebrovascular Diseases. 2022;31(3):106298.
13) Devi K, Ali N, Nasir N, Mahmood SF. VITT with inactivated SARS-CoV-2 vaccine–index case. Human Vaccines & Immunotherapeutics. 2022;18(1):2036556.
14) Hosseinzadeh R, Barary M, Mehdinezhad H, Sio TT, Langer F, Khosravi S. Thrombotic thrombocytopenia After Sinopharm BBIBP‐CorV COVID‐19 vaccination. Research and Practice in Thrombosis and Haemostasis. 2022;6(4):e12750.
15) Bhan C, Bheesham N, Shakuntulla F, Sharma M, Sun C, Weinstein M. An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine—A case report. Annals of Translational Medicine. 2021;9(20)
16) Hasegawa T, Yazaki Y. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination. Circulation Journal. 2022;86(4):723.
17) Kang J. Unusual arm vein thrombosis after the Moderna (mRNA-1273) COVID-19 vaccination—a case report. Annals of palliative medicine. 2022;
18) Gonzalez S, Levine D. UPPER EXTREMITY DEEP VENOUS THROMBOSIS AFTER BNT162B2 MRNA COVID-19 VACCINE. Journal of General Internal Medicine. 2022:S541-S541.